Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study-Reference-Cited by-同舟云学术

Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study

Published:2022-12 Issue:12 Volume:20 Page:2810-2822
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Scully Marie^ORCID,de la Rubia Javier^ORCID,Pavenski Katerina^ORCID,Metjian Ara^ORCID,Knöbl Paul^ORCID,Peyvandi Flora^ORCID,Cataland Spero^ORCID,Coppo Paul^ORCID,Kremer Hovinga Johanna A.^ORCID,Minkue Mi Edou Jessica^ORCID,De Passos Sousa Rui^ORCID,Callewaert Filip^ORCID,Gunawardena Sriya^ORCID,Lin Julie^ORCID

Funder

Sanofi

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15892

Reference33 articles.

1. Thrombotic thrombocytopenic purpura;Kremer Hovinga;Nat Rev Dis Primers,2017

2. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura;Joly;Expert Rev Hematol,2019

3. Multiple major morbidities and increased mortality during long‐term follow‐up after recovery from thrombotic thrombocytopenic purpura;Deford;Blood,2013